Pharma Mar, S.A. total revenue, net income and dynamics of changes in US dollar today
Pharma Mar, S.A. current income and income for the latest reporting periods. Net income of Pharma Mar, S.A. today amounted to 0 $. Net income, revenue and dynamics - the main financial indicators of Pharma Mar, S.A.. Graph of the financial report of Pharma Mar, S.A.. The financial graph of Pharma Mar, S.A. displays the online status: net income, net revenue, total assets. The financial report chart on our website displays information by dates from 30/06/2018 to 30/09/2019.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/09/2019
0 $
-
0 $
-
30/06/2019
21 967 000 $
-64.737 % ↓
-10 838 000 $
-348.236 % ↓
31/03/2019
19 439 000 $
-
-10 481 000 $
-
31/12/2018
29 183 000 $
-
-10 557 000 $
-
30/09/2018
0 $
-
0 $
-
30/06/2018
62 294 000 $
-
4 366 000 $
-
Show:
to
Pharma Mar, S.A. financial report charts
The dates of the latest financial statements of Pharma Mar, S.A.: 30/06/2018, 30/06/2019, 30/09/2019. The dates of the financial statements are determined by the accounting rules. The latest financial report of Pharma Mar, S.A. is available online for such a date - 30/09/2019. Current assets Pharma Mar, S.A. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Pharma Mar, S.A. is 50 751 000 $
Pharma Mar, S.A. quarterly report dates
Total assets Pharma Mar, S.A. refers to the total amount of assets owned by a person or entity. Total assets Pharma Mar, S.A. is 112 537 000 $ Current cash Pharma Mar, S.A. - the sum of all of the cash a company has on the date of report. Current cash Pharma Mar, S.A. is 23 409 000 $ Current debt Pharma Mar, S.A. is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Pharma Mar, S.A. is 60 769 000 $
Total debt Pharma Mar, S.A. is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year. Total debt Pharma Mar, S.A. is 121 746 000 $
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-
20 668 000 $
18 145 000 $
22 594 000 $
-
27 149 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
-
1 299 000 $
1 294 000 $
6 589 000 $
-
35 145 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
-
21 967 000 $
19 439 000 $
29 183 000 $
-
62 294 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-
-4 667 000 $
-9 094 000 $
-12 320 000 $
-12 320 000 $
5 964 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-
-10 838 000 $
-10 481 000 $
-10 557 000 $
-
4 366 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
12 707 000 $
15 209 000 $
-57 025 000 $
-57 025 000 $
-57 025 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
-
26 634 000 $
28 533 000 $
41 503 000 $
-
56 330 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
50 751 000 $
66 874 000 $
100 117 000 $
75 110 000 $
88 272 000 $
97 930 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
112 537 000 $
129 738 000 $
166 103 000 $
157 676 000 $
174 850 000 $
190 618 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
23 409 000 $
39 327 000 $
10 385 000 $
22 745 000 $
26 164 000 $
14 677 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
60 769 000 $
70 810 000 $
68 641 000 $
72 382 000 $
78 483 000 $
94 577 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
121 746 000 $
133 518 000 $
158 606 000 $
140 203 000 $
146 610 000 $
164 485 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
108.18 %
102.91 %
95.49 %
88.92 %
83.85 %
86.29 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
-5 296 000 $
129 000 $
11 401 000 $
21 373 000 $
32 135 000 $
30 023 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-630 000 $
-14 720 000 $
3 721 000 $
3 721 000 $
-11 556 000 $
Last revenue report of Pharma Mar, S.A. was 30/09/2019. According to last financial report total revenue in Pharma Mar, S.A. was 0 US dollar and changed by -64.737% since last year. Net income in Pharma Mar, S.A. was 0 $ in last quartal, net income changes to -348.236%.
Pharma Mar, S.A. stocks data
PHMMF stock price
Pharma Mar, S.A. stock price today, PHMMF stock quote.
